Physician profile
Brandon Mudd
NPI 1902309842
$1,612.13
in general payments reported to CMS, 2019-2025
16 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $333 · 2024: $222 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $631.72 | 2023-2025 | Ams 700, Lithovue, Spaceoar Vue System - 10ml |
| Teleflex LLC | $191.72 | 2025 | Urolift |
| Medtronic, INC. | $184.13 | 2024 | Interstim |
| Calyxo, INC. | $130.95 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $72.54 | 2025 | |
| Olympus America INC. | $58.69 | 2025 | Itind System |
| Galvanize Therapeutics, INC | $55.00 | 2023 | Aliya System |
| Sumitomo Pharma America, INC. | $51.81 | 2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $48.45 | 2025 | |
| Merck Sharp & Dohme LLC | $43.72 | 2025 | Lynparza, Keytruda Qlex, Keytruda |
| Accord Healthcare, INC. | $33.69 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.34 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.60 | 2025 | |
| Abbvie INC. | $23.35 | 2025 | |
| Immunitybio, INC. | $16.15 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.27 | 2025 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Mudd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.